Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Publication year range
1.
Gan To Kagaku Ryoho ; 36(12): 2045-8, 2009 Nov.
Article in Japanese | MEDLINE | ID: mdl-20037318

ABSTRACT

A 78-year-old man underwent a radical resection for esophageal cancer (Stage III) and cardiac gastric cancer (Stage IA) at another hospital 2 years ago. After the operation, he was followed at that hospital. In 2008, abdominal CT scan and FDG-PET/CT revealed a liver tumor. He was referred to our hospital and was diagnosed as esophageal cancer with liver metastasis. He received chemo-radiation therapy (CRT). The regimen was docetaxel hydrate (30 mg/m2, day 1, 8, 29 and 36) and S-1 (60 mg/m2, day 1-14 and day 29-45) with radiation (45 Gy) for liver metastasis. He finished the CRT without any hematotoxicity, liver disorder and non-hematotoxic adverse event (grade 3). Abdominal CT was done 2 months after the end of CRT and revealed that the tumor lesion disappeared completely. The patient is alive for 11 months after the CRT without any evidence of recurrence. The tumor disappeared completely for the last 11 months. We conclude that CRT is safe and very effective for esophageal cancer with liver metastasis.


Subject(s)
Esophageal Neoplasms/pathology , Liver Neoplasms/secondary , Liver Neoplasms/therapy , Aged , Antineoplastic Agents/administration & dosage , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Combined Modality Therapy , Docetaxel , Drug Combinations , Esophageal Neoplasms/surgery , Humans , Liver Neoplasms/drug therapy , Liver Neoplasms/radiotherapy , Male , Oxonic Acid/administration & dosage , Taxoids/administration & dosage , Tegafur/administration & dosage
SELECTION OF CITATIONS
SEARCH DETAIL
...